Decisions of Sampo plc's Annual General Meeting

Udgivet den 19-05-2021  |  kl. 11:15  |  

SAMPO PLC                 DECISIONS OF GENERAL MEETING    19 May 2021 at 2:15 pm


Decisions of Sampo plc's Annual General Meeting

The Annual General Meeting of Sampo plc, held today on 19 May 2021, decided to distribute a dividend of EUR 1.70 per share for 2020. The record date for dividend payment is 21 May 2021 and the dividend will be paid on 28 May 2021. The Annual General Meeting adopted the financial accounts for 2020 and discharged the Board of Directors and the CEO from liability for the financial year.

The Annual General Meeting elected eight members to the Board of Directors. The following members were re-elected to the Board: Christian Clausen, Fiona Clutterbuck, Georg Ehrnrooth, Jannica Fagerholm, Johanna Lamminen, Risto Murto and Björn Wahlroos. Markus Rauramo was elected as a new member to the Board. The Members of the Board were elected for a term continuing until the close of the next Annual General Meeting.

At its organizational meeting, the Board elected Björn Wahlroos as Chair and Jannica Fagerholm as Vice Chair. Christian Clausen, Risto Murto and Björn Wahlroos (Chair) were elected to the Nomination and Remuneration Committee as well as Fiona Clutterbuck, Georg Ehrnrooth, Jannica Fagerholm (Chair), Johanna Lamminen and Markus Rauramo were elected to the Audit Committee.

All the Board members have been determined to be independent of the company and its major shareholders under the rules of the Finnish Corporate Governance Code 2020. The curriculum vitaes of the Board Members are available at www.sampo.com/board.

The Annual General Meeting decided to pay the following fees to the members of the Board of Directors until the close of the 2022 Annual General Meeting: the Chair of the Board will be paid an annual fee of EUR 184,000 and other members of the Board will be paid EUR 95,000 each. Furthermore, the members of the Board and its Committees will be paid the following annual fees: the Vice Chair of the Board EUR 26,000, the Chair of the Audit Committee EUR 26,000 and the member of the Audit Committee EUR 6,000. A Board member shall, in accordance with the resolution of the Annual General Meeting, acquire Sampo plc's A shares at the price paid in public trading for 50 per cent of his/her annual fee excluding taxes and similar payments.

The Annual General Meeting accepted Sampo plc's Remuneration Report for Governing Bodies. The resolution is advisory.

Deloitte Ltd was elected as Auditor. The Auditor will be paid a fee determined by an invoice approved by Sampo. Jukka Vattulainen, APA, will act as the principally responsible auditor.

The Annual General Meeting authorized the Board to repurchase a maximum of 50,000,000 Sampo A shares. The price paid for the shares repurchased under the authorization shall be based on the current market price of Sampo A shares on the securities market. The authorization will be valid until the close of the next Annual General Meeting, nevertheless not more than 18 months after AGM's decision.

There were altogether 330,774,332 shares (59.56 per cent of shares) and 335,574,332 votes (59.91 per cent of all votes) in the company represented, including advance voting and a proxy representation, at the Annual General Meeting. The voting results of the AGM are available on a table attached to this release.

The proposals approved by the Annual General Meeting as well as Sampo plc's Remuneration Report for Governing Bodies were published in stock exchange releases on 11 February and 17 March 2021. The documents are available in their entirety at Sampo's AGM website at www.sampo.com/agm.

The minutes of the Annual General Meeting will be available for viewing at the AGM website and at Sampo plc's head office at Fabianinkatu 27, Helsinki, Finland, by the end of 2 June 2021.


SAMPO PLC

Jarmo Salonen
Head of Investor Relations and Group Communications
tel. +358 10 516 0030

Maria Silander
Communications Manager, Media Relations
tel. +358 10 516 0031

Mirko Hurmerinta
IR & Communications Specialist
tel. +358 10 516 0032

Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com

ANNEX

Voting results of the Annual General Meeting

Board proposals for the AGM For Against Abstained from voting
Adoption of the Financial Statements 331,393,502
(98.87%)
3,775,321
(1.13%)
402,267
(0.12%)
Resolution on the use of the profit shown on the balance sheet and the payment of dividend 334,685,313
(99.74%)
878,061
(0.26%)
10,958
(0.00%)
Resolution on the discharge of the members of the Board of Directors and the Group CEO and President from liability for the financial year 2020 329,381,908
(99.92%)
273,367
(0.08%)
585,144
(0.18%)
Handling of the Remuneration Report for Governing Bodies 217,928,781
(65.00%)
117,365,936
(35.00%)
272,589
(0.08%)
Resolution on the remuneration of the members of the Board of Directors 335,009,963
(99.84%)
530,132
(0.16%)
29,821
(0.01%)
Resolution on the number of members of the Board of Directors 335,540,174
(100.00%)
799
(0.00%)
28,721
(0.01%)
Election of the members of the Board of Directors 304,764,402
(92.37%)
25,161,160
(7.63%)
5,644,425
(1.71%)
Resolution on the remuneration of the Auditor 328,777,671
(97.98%)
6,767,601
(2.02%)
27,298
(0.01%)
Election of the Auditor 330,655,851
(99.01%)
3,317,614
(0.99%)
1,593,932
(0.48%)
Authorizing the Board of Directors to decide on the repurchase of the company's own shares 335,221,209
(99.95%)
174,965
(0.05%)
172,342
(0.05%)


\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed